Full Press Release Details
Cadre Holdings Reports First Quarter 2022 Financial Results
Completes Second Accretive Acquisition Since IPO with Agreement to Add Leading Supplier of Chemical Illumination Solutions to U.S. and NATO Military Forces
Raises Guidance to Full Year 2022 Net Sales of $444.0 to $452.0 Million and Adjusted EBITDA of $72.5 to $77.5 Million Based on Continued Execution of Strategic Objectives
JACKSONVILLE, Fla., May 12, 2022 - Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three months ended March 31, 2022.
First Quarter 2022 Highlights
"Following a year of record net sales and adjusted EBITDA, we continue to capitalize on attractive long-term tailwinds and recurring demand drivers in our entrenched mission-critical first responder markets," said Warren Kanders, CEO and Chairman. "During the quarter, we achieved pricing growth that significantly exceeded our target, generated strong adjusted EBITDA conversion, and increased our backlog substantially. In the second half of the year, we expect a more favorable product portfolio mix and based on our success executing strategic objectives focused on accelerating growth we have increased our full year 2022 outlook."
Mr. Kanders added, "Our resilient operating model continues to drive strong free cash flow generation that is enabling us to capitalize on attractive opportunities to unlock long-term shareholder value. In addition to January's accretive acquisition of a premiere duty gear brand, which further expanded our international presence, we are excited to acquire the world leader in chemical light solutions for U.S. and NATO military forces. In a short period of time, we have delivered on the strategy we laid out to investors, adding high margin companies with leading market positions and strong recurring revenues and cash flows. Importantly, we maintain a robust acquisition pipeline, complementing our core organic growth initiatives."
First Quarter 2022 Operating Results
For the quarter ended March 31, 2022, Cadre generated net sales of $104.4 million, as compared to $110.5 million for the quarter ended March 31, 2021. The decline was primarily the result of a large US Federal duty gear shipment in last year's first quarter, combined with strong commercial demand and higher demand for crowd control products in the comparable period last year.
For the quarter ended March 31, 2022, Cadre generated gross profit of $40.2 million, as compared to $44.0 million for the quarter ended March 31, 2021.
Gross profit margin was 38.5% for the quarter ended March 31, 2022, as compared to 39.8% for the quarter ended March 31, 2021, mainly driven by less favorable portfolio mix, partially offset by price.
Net loss was $10.2 million for the quarter ended March 31, 2022, as compared to net income of $6.9 million for the three months ended March 31, 2021. The decrease resulted primarily from the change in year over year revenue and stock-based compensation expense of $23.6 million.
Cadre generated $14.2 million of Adjusted EBITDA for the quarter ended March 31, 2022, as compared to $20.2 million for the quarter ended March 31, 2021. Adjusted EBITDA margin was 13.6% for the quarter ended March 31, 2022, as compared to 18.3% for the prior year period.
Product segment gross margin was 40.1% for the first quarter compared to 40.7% for the prior year period.
Distribution segment gross margin was 24.6% for the first quarter compared to 25.3% for the prior year period.
Liquidity, Cash Flows and Capital Allocation
Acquisition of Cyalume Technologies
On May 5, 2022, Cadre announced the completion of its accretive acquisition of Cyalume Technologies, a leading manufacturer of proprietary chemical illumination solutions for military, first responder and other commercial applications. The purchase price for the acquisition was $35.0 million, subject to customary adjustments for net working capital, transaction expenses and indebtedness, and was funded through a draw on its existing credit facilities.
On April 21, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on May 13, 2022, to shareholders of record as of the close of business on the record date of May 2, 2022. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.
Cadre increased its full-year guidance and expects to generate net sales in 2022 of between $444.0 million and $452.0 million and adjusted EBITDA in 2022 of between $72.5 and $77.5 million. Cadre expects EBITDA conversion in the range of 92-95% for the full year.
Cadre management will host a conference call on Thursday, May 12, 2022, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.
A replay of the call will be available through May 26, 2022. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.
Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals,
explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland and Med-Eng , amongst others.
Forward-Looking Statements
Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company's financial results are more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.
Cadre Holdings, Inc.
Leon Berman / Matt Berkowitz
212-477-8438 / 212-227-7098
Jonathan Keehner / Andrew Siegel
Joele Frank, Wilkinson Brimmer Katcher
CADRE HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| March 31, 2022 | December 31, 2021 | |||||
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents | $ | 9,877 | $ | 33,857 | ||
| Accounts receivable, net of allowance for doubtful accounts of $749 and $645, respectively | 52,001 | 48,344 | ||||
| Inventories | 69,401 | 63,978 | ||||
| Prepaid expenses | 7,747 | 10,353 | ||||
| Other current assets | 4,360 | 3,171 | ||||
| Assets held for sale | 271 | 278 | ||||
| Total current assets | 143,657 | 159,981 | ||||
| Property and equipment, net of accumulated depreciation and amortization of $38,631 and $37,171, respectively | 35,729 | 33,053 | ||||
| Deferred tax assets, net | 12,979 | 7,059 | ||||
| Intangible assets, net | 50,158 | 42,415 | ||||
| Goodwill | 72,510 | 66,262 | ||||
| Other assets | 5,965 | 3,026 | ||||
| Total assets | $ | 320,998 | $ | 311,796 | ||
| Liabilities, Mezzanine Equity and Shareholders' Equity | ||||||
| Current liabilities | ||||||
| Accounts payable | $ | 27,477 | $ | 19,328 | ||
| Accrued liabilities | 34,363 | 40,736 | ||||
| Income tax payable | 2,239 | 1,255 | ||||
| Liabilities held for sale | 120 | 128 | ||||
| Current portion of long-term debt | 11,700 | 13,174 | ||||
| Total current liabilities | 75,899 | 74,621 | ||||
| Long-term debt | 144,661 | 146,516 | ||||
| Deferred tax liabilities | 3,799 | 1,297 | ||||
| Other liabilities | 694 | 722 | ||||
| Total liabilities | 225,053 | 223,156 | ||||
| Mezzanine equity | ||||||
| Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021) | - | - | ||||
| Shareholders' equity | ||||||
| Common stock ($0.0001 par value, 190,000,000 shares authorized, 34,782,271 shares and 34,383,350 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively) | 3 | 3 | ||||
| Additional paid-in capital | 144,978 | 127,606 | ||||
| Accumulated other comprehensive income (loss) | 931 | (1,917) | ||||
| Accumulated deficit | (49,967) | (37,052) | ||||
| Total shareholders' equity | 95,945 | 88,640 | ||||
| Total liabilities, mezzanine equity and shareholders' equity | $ | 320,998 | $ | 311,796 |
CADRE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
| Three Months Ended March 31, | ||||||
| 2022 | 2021 | |||||
| Net sales | $ | 104,406 | $ | 110,536 | ||
| Cost of goods sold | 64,217 | 66,577 | ||||
| Gross profit | 40,189 | 43,959 | ||||
| Operating expenses | ||||||
| Selling, general and administrative | 53,950 | 28,051 | ||||
| Restructuring and transaction costs | 599 | 321 | ||||
| Related party expense | 122 | 153 | ||||
| Total operating expenses | 54,671 | 28,525 | ||||
| Operating (loss) income | (14,482) | 15,434 | ||||
| Other expense | ||||||
| Interest expense | (1,490) | (5,044) | ||||
| Other expense, net | (205) | (44) | ||||
| Total other expense, net | (1,695) | (5,088) | ||||
| (Loss) income before provision for income taxes | (16,177) | 10,346 | ||||
| Benefit (provision) for income taxes | 6,012 | (3,482) | ||||
| Net (loss) income | $ | (10,165) | $ | 6,864 | ||
| Net (loss) income per share: | ||||||
| Basic | $ | (0.30) | $ | 0.25 | ||
| Diluted | $ | (0.30) | $ | 0.25 | ||
| Weighted average shares outstanding: | ||||||
| Basic | 34,446,318 | 27,483,350 | ||||
| Diluted | 34,446,318 | 27,483,350 |
CADRE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended March 31, | ||||||
| 2022 | 2021 | |||||
| Cash Flows From Operating Activities: | ||||||
| Net (loss) income | $ | (10,165) | $ | 6,864 | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Depreciation and amortization | 3,544 | 3,539 | ||||
| Amortization of original issue discount and debt issue costs | 111 | 677 | ||||
| Deferred income taxes | (6,951) | 3,319 | ||||
| Stock-based compensation | 23,588 | - | ||||
| (Recoveries from) provision for losses on accounts receivable | 45 | (91) | ||||
| Foreign exchange loss | 253 | 109 | ||||
| Changes in operating assets and liabilities, net of impact of acquisition: | ||||||
| Accounts receivable | (1,693) | (5,626) | ||||
| Inventories | (2,956) | (2,496) | ||||
| Prepaid expenses and other assets | 3,158 | (141) | ||||
| Accounts payable and other liabilities | (18) | 10,678 | ||||
| Net cash provided by operating activities | 8,916 | 16,832 | ||||
| Cash Flows From Investing Activities: | ||||||
| Purchase of property and equipment | (950) | (788) | ||||
| Business acquisition, net of cash acquired | (19,787) | - | ||||
| Net cash used in investing activities | (20,737) | (788) | ||||
| Cash Flows From Financing Activities: | ||||||
| Proceeds from revolving credit facilities | - | 88,593 | ||||
| Principal payments on revolving credit facilities | - | (88,593) | ||||
| Principal payments on term loans | (2,506) | (566) | ||||
| Principal payments on insurance premium financing | (1,474) | (917) | ||||
| Payment of capital leases | (11) | (7) | ||||
| Taxes paid in connection with employee stock transactions | (6,216) | - | ||||
| Dividends distributed | (2,750) | - | ||||
| Net cash used in financing activities | (12,957) | (1,490) | ||||
| Effect of foreign exchange rates on cash and cash equivalents | 798 | 13 | ||||
| Change in cash and cash equivalents | (23,980) | 14,567 | ||||
| Cash and cash equivalents, beginning of period | 33,857 | 2,873 | ||||
| Cash and cash equivalents, end of period | $ | 9,877 | $ | 17,440 | ||
| Supplemental Disclosure of Cash Flows Information: | ||||||
| Cash (received) paid for income taxes, net | $ | (100) | $ | 15 | ||
| Cash paid for interest | $ | 1,282 | $ | 4,292 | ||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | ||||||
| Accruals and accounts payable for capital expenditures | $ | 119 | $ | - |
CADRE HOLDINGS, INC.
| Three months ended March 31, 2022 | ||||||||||||
| Reconciling | ||||||||||||
| Products | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 85,386 | $ | 24,096 | $ | (5,076) | $ | 104,406 | ||||
| Cost of goods sold | 51,120 | 18,172 | (5,075) | 64,217 | ||||||||
| Gross profit | $ | 34,266 | $ | 5,924 | $ | (1) | $ | 40,189 |
| Three months ended March 31, 2021 | ||||||||||||
| Reconciling | ||||||||||||
| Products | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 93,818 | $ | 22,660 | $ | (5,942) | $ | 110,536 | ||||
| Cost of goods sold | 55,594 | 16,921 | (5,938) | 66,577 | ||||||||
| Gross profit | $ | 38,224 | $ | 5,739 | $ | (4) | $ | 43,959 |
CADRE HOLDINGS, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
| Year ended | Three Months Ended March 31, | LTM | |||||||||||
| December 31, 2021 | 2021 | 2022 | March 31, 2022 | ||||||||||
| Net (loss) income | $ | 12,661 | $ | 6,864 | $ | (10,165) | $ | (4,368) | |||||
| Add back: | |||||||||||||
| Depreciation and amortization | 13,718 | 3,539 | 3,544 | 13,723 | |||||||||
| Interest expense | 16,425 | 5,044 | 1,490 | 12,871 | |||||||||
| (Benefit) provision for income taxes | 6,531 | 3,482 | (6,012) | (2,963) | |||||||||
| EBITDA | $ | 49,335 | $ | 18,929 | $ | (11,143) | $ | 19,263 | |||||
| Add back: | |||||||||||||
| Restructuring and transaction costs (1) | 3,430 | 321 | 599 | 3,708 | |||||||||
| Loss on extinguishment of debt (2) | 15,155 | - | - | 15,155 | |||||||||
| Other expense, net (3) | 947 | 44 | 205 | 1,108 | |||||||||
| Stock-based compensation expense (4) | 355 | - | 23,723 | 24,078 | |||||||||
| Stock-based compensation payroll tax expense (5) | - | - | 298 | 298 | |||||||||
| LTIP bonus (6) | 2,162 | 952 | 384 | 1,594 | |||||||||
| Amortization of inventory step-up (7) | - | - | 153 | 153 | |||||||||
| Adjusted EBITDA | $ | 71,384 | $ | 20,246 | $ | 14,219 | $ | 65,357 | |||||
| Less: Capital expenditures | (3,029) | (788) | (1,069) | (3,310) | |||||||||
| Adjusted EBITDA less capital expenditures | $ | 68,355 | $ | 19,458 | $ | 13,150 | $ | 62,047 | |||||
| Adjusted EBITDA conversion rate (8) | 96 | % | 96 | % | 92 | % | 95 | % | |||||
| Adjusted EBITDA margin (9) | 16.7 | % | 18.3 | % | 13.6 | % |